Meitheal Pharmaceuticals, Inc.’s Post

🔬 #Microbiome Update: Delving into the world of Strain Tracking and Engraftment Persistence Analysis! These cutting-edge tools are proving invaluable in evaluating the efficacy, safety, and dynamics of Live Biotherapeutic Products (LBPs), Fecal Microbiota Transplants (FMTs), and probiotics. Here are just some of the key benefits: 1️⃣ Differentiation and tracking of interventional strains from endogenous host strains. This is crucial even in complex environments like FMTs. 2️⃣ Monitoring the ability of interventional strains to colonize, persist, and modify the host's microbial community. The ability to distinguish between endogenous and interventional strains paves the way for assessing strain-specific behavior. 3️⃣ Correlating engraftment patterns to clinical outcomes or other significant phenotypes. This can help illuminate the mechanism of action and guides the design of next-generation consortia, dosages, or delivery methods. Discover more about one of the latest advancements in the microbiome field by clicking below: https://hubs.ly/Q02bYSd40 #Microbiology #Probiotics #HealthTech #Innovation #Research

Homocystinuria Market: Breakthrough Forecast Study by DelveInsight Predicts Astounding Growth in the Upcoming Years | Orphan Technologies (OT-58), Aeglea Biotherapeutics (ACN 00177) #Finance #FinancialMarket #MarketingSales #PharmaceuticalsBiotech

📈 Exciting Growth Ahead in the Human Microbiome Market! Download Free PDF Brochure: https://lnkd.in/dTJ9Bjpc The report "#HumanMicrobiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT) - Global Forecast to 2029" highlights a remarkable projected growth from USD 0.3 billion in 2023 to USD 1.7 billion by 2029, with a CAGR of 36.1%. Key drivers include technological advancements and rising awareness of personalized medicine. However, regulatory challenges and limited understanding of microbial interactions remain obstacles. #Microbiome #Healthcare #Biotechnology #MarketGrowth #PersonalizedMedicine #Innovation Seres Therapeutics Enterome 4D Pharmacy Management Systems, Inc. INTERNATIONAL FLAVORS & FRAGRANCES I.F.F. OptiBiotix Health Plc Ferring Pharmaceuticals Synlogic Second Genome Inc. Vedanta Biosciences, Inc. YSOPIA Bioscience Flightpath Biosciences, Inc. Finch Therapeutics AOBiome Therapeutics, Inc. BioGaia AB Quantbiome. (DBA OMBRE) Viome Life Sciences, INC. BIOHM Health DayTwo Bione Luxia Scientific Metabiomics Floré by Sun Genomics Seed Health Gnubiotics Sciences SA

https://lnkd.in/dmJh5cjK A comprehensive review by the APC team describing the mechanism by which therapeutics used in the treatment of IBD impact the microbiome and vice versa. Highlighting why the #gutmicrobiome needs to be studied in conjunction with drug development programs. Drugs mentioned are used more broadly than to just treat IBD. #therapeutics #ibd #microbiome #drugdevelopment

⚛️ Uncovering the full potential of strain tracking and engraftment persistence analysis: In a recent case study we evaluated bacterial strain tracking and engraftment. The study aimed to understand whether bacterial strains introduced via fecal microbiota transplantation (FMT) could be transferred from a pregnant individual to her newborn infant, born 26 weeks later. Here are some of the key findings: 1️⃣ The study demonstrated the ability to track strains from one environment to another, revealing the persistence of these strains over time. 2️⃣ Notably, the research showed that specific bacterial strains administered to the mother via FMT were found in the infant, suggesting cross-generational transfer of the strains. 3️⃣ This vertical transfer of bacterial strains from a pregnant mother to an infant represents a potential route for shaping the infant gut microbiota - a critical aspect of early-life health. This research is a powerful testament to the precision and sensitivity of modern microbiome profiling techniques. It opens up exciting new possibilities for understanding how microbiomes are shaped and how they can be manipulated for better health outcomes. Find out more by clicking below or get in touch with one of the team at CosmosID or Clinical Microbiomics https://hubs.li/Q02cFyTH0 #Microbiology #Probiotics #HealthTech #Innovation #Research

A preclinical study published in the journal 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 demonstrates that diverse, multistrain microbiome communities protect against pathogen colonization of the gut by consuming the available nutrients, necessary to bacterial growth and spread. https://lnkd.in/da2363j7 #medicine #lifescience #biomedicalresearch #microbiome

As per DelveInsight Business Research LLP’s analysis, the Anorexia Nervosa market size in the 7MM was found to be USD 63 million in 2021, and it is anticipated to grow at a significant CAGR by 2032. Pharma and biotech giants are pivotal in reshaping the Anorexia Nervosa market by innovating treatment options, improving patient care, and advancing understanding of this complex disorder. Currently, some of the key players such as Amgen, COMPASS Pathways, Benuvia Therapeutics Inc. Artelo Biosciences, Inc., Receptor Life Sciences, Inc., Pfizer, and others are developing novel Anorexia Nervosa drugs. Read More: https://lnkd.in/dcq72Buf #healthcare #biotechnology #lifesciences #market #marketforecast #marketanalysis #fda #healthcaremarket #healthcareindustry #marketoutlook

Virology Specimen Collection Market Size, Share & Trends Analysis Report By Application (Diagnostics, Research) By Product Type (Swabs, Blood Collection Kits, Viral Transport Media Others) By End users (Hospitals and Clinics, Diagnostic Laboratories Others), Global Economy Insights, Regional Outlook, Growth Potential, Russia-Ukraine war analysis, Price Trend, Competitive Market Share & Forecast, 2023 - 2031. 🌐IMIR Market Research Pvt. Ltd. #virology #specimen #collection #intellectualmarketinsights #growth #share #covid19impact #marketresearchreports #northamerica #europe #asiapacific #latinamerica #africa 📚Get this Report at Discounted Price📝👇https://lnkd.in/d7sMyxNj   📚Top Key Players Are:👇 CERBA The Doctors Laboratory Viapath Fujirebio Europe Monogram Biosciences Cerba Research Health Services Laboratories hVIVO Viroclinics-DDL Institute of Human Virology at the University of Maryland School of Medicine Institute of Virology, Vaccines and Sera “Torlak” Dewpoint Therapeutics Enanta Pharmaceuticals Analytical Lab Group AbleTo Inc. Invivyd ROME Therapeutics eGenesis, Inc. Arbutus Biopharma Corporation Technogenetics Wageningen Bioveterinary Research Nelson Laboratories Bozeman, LLC AiCuris Anti-infective Cures AG 360biolabs, a BioAgilytix company

Get a glimpse of the most common and critical cell-surface receptors involved in health and disease conditions! #HealthcareInnovation #MedicalResearch #HealthTech #Biotechnology #CellBiology #MedicalScience #HealthAwareness #DiseaseResearch #HealthEducation #ScientificDiscovery